Lieber Institute for Brain Development

October ended and November began with the announcement of three new venture capital and equity funds with more than $1.3bn for health care, life science and biopharmaceutical investments. Revelation P

Although family-owned Boehringer Ingelheim GmbH is the only private firm in the top 20 largest biopharmas, its executives are quick to explain that most of their operations function in the same way

BridgeBio Pharma, Inc. employs a business model of acquiring rights to or partnering with academic and institutional research in monogenic diseases and genetic cancer indications, often forming singl